Position in APRE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2
-$1,640 QoQ
Shares Held
3
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 28 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. APRE ranks #553 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in APRE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2 | 3 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,642 | 2,153 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,098 | 2,461 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4 | 3 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13 | 8 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6 | 3 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,525 | 5,935 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8 | 3 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $12 | 3 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20 | 3 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $14 | 3 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $12 | 3 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9 | 3 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,992 | 674 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,519 | 25,739 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,861 | 5,942 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,748 | 10,332 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,783 | 5,260 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $215 | 75 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $6,451 | 1,322 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,673 | 2,485 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,483 | 708 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $962 | 40 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $123,242 | 3,178 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $152,144 | 4,377 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||